"Dibenzothiazepines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D003987
|
| MeSH Number(s) |
D02.886.680.702.500 D03.633.300.276
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Dibenzothiazepines".
Below are MeSH descriptors whose meaning is more specific than "Dibenzothiazepines".
This graph shows the total number of publications written about "Dibenzothiazepines" by people in this website by year, and whether "Dibenzothiazepines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 1 | 1 | 2 |
| 2017 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Dibenzothiazepines" by people in Profiles.
-
Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naïve patients with a first-episode of non-affective psychosis. Psychopharmacology (Berl). 2018 01; 235(1):245-255.
-
A review of FDA-approved treatment options in bipolar depression. CNS Spectr. 2013 Dec; 18 Suppl 1:4-20; quiz 21.
-
The role of extended-release quetiapine fumarate monotherapy in the treatment of patients with major depressive disorder. Expert Rev Neurother. 2013 Nov; 13(11):1161-82.
-
Bipolar disorder--a focus on depression. N Engl J Med. 2011 04 21; 364(16):1581; author reply 1582.
-
Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study. Int J Neuropsychopharmacol. 2010 Apr; 13(3):305-20.
-
Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study. Acta Psychiatr Scand. 2005 Mar; 111(3):232-43.
-
High degree of tolerability for monotherapy with high doses of quetiapine: a case report. J Clin Psychiatry. 2002 Nov; 63(11):1048-9.